TET2 repression contributes to EGFR TKI resistance in EGFR-mutant non-small cell lung cancer through regulating AXIN2 methylation
Hangjie Ying(Nanjing University of Chinese Medicine), Ying Jin(Chinese Academy of Sciences)
Cited by 0
Related Papers
Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
|Clinical Cancer Research|2021|115